evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

5 questions · 5 findings · 1 reviews · Pregnancy and Childbirth

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 2 · 40%GRADE not reported 0 · 0%Very low 1 · 20%Low 0 · 0%Moderate 2 · 40%High 0 · 0%

Summary of findings for subcutaneous terbutaline vs no tocolytic agent, whilst awaiting emergency delivery

Abnormal FHR tracing · women in labour with signs of fetal distress and a fetal scalp pH < 7.25, for whom the decision had been made for emergency delivery

Summary of findings for subcutaneous terbutaline probably leads to lower abnormal FHR tracing compared with no tocolytic agent, whilst awaiting emergency delivery (moderate certainty).

1 finding from 1 review

Summary of findings for subcutaneous terbutaline with continuation of oxytocic infusion vs cessation of oxytocic infusion without tocolytic agent

Abnormal FHR tracing · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress

The review found no eligible studies for this question.

1 finding from 1 review

Summary of findings for selective ß2‐adrenergic agonist vs no tocolytic agent, whilst awaiting emergency delivery

Abnormal FHR as defined by trial authors (FHR tracing not improved) · women with fetal distress for whom the decision had been made to delivery by emergency caesarean section

Summary of findings for selective ß2‐adrenergic agonist probably leads to lower abnormal FHR as defined by trial authors (FHR tracing not improved) compared with no tocolytic agent, whilst awaiting emergency delivery (moderate certainty).

1 finding from 1 review